JEVTANA
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CABAZITAXEL 60 MG / 1.5 ML
Available from:
SANOFI - AVENTIS ISRAEL LTD
ATC code:
L01CD04
Pharmaceutical form:
CONCENTRATE FOR SOLUTION FOR INFUSION
Administration route:
I.V
Manufactured by:
SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY
Therapeutic group:
CABAZITAXEL
Therapeutic indications:
In combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mHRPC) previously treated with a docetaxel-based treatment regimen
Authorization date:
2012-11-01
